Full metadata record

DC Field Value Language
dc.contributor.authorOh, Hyun-A-
dc.contributor.authorKim, Donghak-
dc.contributor.authorLee, Soo Hyun-
dc.contributor.authorJung, Byung Hwa-
dc.date.accessioned2024-01-20T07:31:53Z-
dc.date.available2024-01-20T07:31:53Z-
dc.date.created2021-09-05-
dc.date.issued2015-03-25-
dc.identifier.issn0731-7085-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/125644-
dc.description.abstractA simple and rapid quantitative analytical method for the simultaneous detection of celecoxib and its two main metabolites, hydroxycelecoxib (celecoxib-OH) and celecoxib carboxylic acid (celecoxib-COOH), in rat plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed. The plasma sample was prepared through simple protein precipitation, and the reconstitution solution (0.1% formic acid in 50% methanol) was optimized to achieve the best peak shape and recovery. The analytes were separated using an Atlantis T3 column (2.1 mm x 100 mm, 3 mu m), and the mobile phase was composed of 10 mM ammonium formate in either 5% acetonitrile or 95% acetonitrile. The detection of the analytes was performed in alternating polarity switching mode using electrospray ionization. As celecoxib-OH and celecoxib-COOH were slightly unstable following freeze-thaw cycles and long-term storage at -80 degrees C in stability tests, every analysis was carefully conducted with one-freeze thaw cycle and a short storage duration (<1 week). Acceptable accuracy (<15%) and precision (<15%) were obtained in intra- and inter-day validations. The method was successfully applied to the pharmacokinetic study of celecoxib, celecoxib-OH and celecoxib-COOH following the oral administration of celecoxib in rats at a dose of 10 mg/kg. Comparing the related pharmacokinetic parameters of celecoxib and its metabolites, celecoxib was quickly metabolized into celecoxib-OH and subsequently converted to celecoxib-COOH in short intervals. The AUCs for the two metabolites were less than 10% of that for celecoxib, indicating that the rate of celecoxib metabolism was low. (C) 2014 Elsevier B.V. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER SCIENCE BV-
dc.subjectHUMAN PLASMA-
dc.subjectCLINICAL PHARMACOKINETICS-
dc.subjectCOLORECTAL ADENOMA-
dc.subjectCOX-2 INHIBITORS-
dc.subjectPREVENTION-
dc.subjectEXCRETION-
dc.subjectDISEASE-
dc.subjectTISSUE-
dc.subjectMS/MS-
dc.titleSimultaneous quantitative determination of celecoxib and its two metabolites using liquid chromatography-tandem mass spectrometry in alternating polarity switching mode-
dc.typeArticle-
dc.identifier.doi10.1016/j.jpba.2014.12.004-
dc.description.journalClass1-
dc.identifier.bibliographicCitationJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, v.107, pp.32 - 39-
dc.citation.titleJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS-
dc.citation.volume107-
dc.citation.startPage32-
dc.citation.endPage39-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000351116900006-
dc.identifier.scopusid2-s2.0-84921303193-
dc.relation.journalWebOfScienceCategoryChemistry, Analytical-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusHUMAN PLASMA-
dc.subject.keywordPlusCLINICAL PHARMACOKINETICS-
dc.subject.keywordPlusCOLORECTAL ADENOMA-
dc.subject.keywordPlusCOX-2 INHIBITORS-
dc.subject.keywordPlusPREVENTION-
dc.subject.keywordPlusEXCRETION-
dc.subject.keywordPlusDISEASE-
dc.subject.keywordPlusTISSUE-
dc.subject.keywordPlusMS/MS-
dc.subject.keywordAuthorCelecoxib-
dc.subject.keywordAuthorCelecoxib metabolites-
dc.subject.keywordAuthorQuantitation-
dc.subject.keywordAuthorLiquid chromatography-tandem mass spectrometry-
dc.subject.keywordAuthorAlternating polarity switching-
Appears in Collections:
KIST Article > 2015
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE